Details werden geladen...
Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026 | The Manila Times
Not intended for US and UK media
Ähnliche Seiten
Genmab to Highlight Advances Across Its Oncology Portfolio at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2026 Congress | The ...
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/genmab-to-highlight-advances-across-its-oncology-portfolio-at-the-2026-american-society-of-clinical-oncology-asco-annual-meeting-and-the-european-hematology-association-eha-2026-congress/2349701Lexitas Recognized Across Multiple Categories in Daily Report’s Best Of 2026 Awards | The Manila Times
https://www.manilatimes.net/2026/05/21/tmt-newswire/globenewswire/lexitas-recognized-across-multiple-categories-in-daily-reports-best-of-2026-awards/2348611Anker Unveils Next-Generation Products Across Brands at Anker Day 2026 | The Manila Times
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/anker-unveils-next-generation-products-across-brands-at-anker-day-2026/2349742IUX Highlights H1 2026 Award Recognition Across Global Industry Platforms | The Manila Times
https://www.manilatimes.net/2026/05/18/tmt-newswire/globenewswire/iux-highlights-h1-2026-award-recognition-across-global-industry-platforms/2345886Asher Biotherapeutics Announces Two Presentations at the ASCO 2026 Annual Meeting Highlighting Clinical Progress Across Its CD8-Targeted Cytokine Pipeline | The Manila Times
https://www.manilatimes.net/2026/05/22/tmt-newswire/globenewswire/asher-biotherapeutics-announces-two-presentations-at-the-asco-2026-annual-meeting-highlighting-clinical-progress-across-its-cd8-targeted-cytokine-pipeline/2349690